Jiaqi Chen

Key Laboratory Of Animal Nutrition And Feed Science In East China, Ministry Of Agriculture And Key Laboratory Of Molecular Animal Nutrition Ministry Of Education
Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Dietary Supplementation of Protease and/or Amylase Improves Growth Performance, Digestive Function, and Intestinal Health of Weaned Piglets.

Dietary Supplementation of Protease and/or Amylase Improves Growth Performance, Digestive Function, and Intestinal Health of Weaned Piglets.

Journal: Animals : an open access journal from MDPI

Published: July 15, 2026

Effects of dietary probiotics and their combination with copper-loaded montmorillonite on growth performance, intestinal digestive function and nitrogen metabolism in yellow-feathered broilers.

Effects of dietary probiotics and their combination with copper-loaded montmorillonite on growth performance, intestinal digestive function and nitrogen metabolism in yellow-feathered broilers.

Journal: Poultry science

Published: May 12, 2026

The CXCL5/CXCR2 Axis Attenuates Ferroptosis in Intrahepatic Cholangiocarcinoma Through the Positive Feedback Loop Between PTGS2 Transcriptional Activation and Neutrophil Recruitment.

The CXCL5/CXCR2 Axis Attenuates Ferroptosis in Intrahepatic Cholangiocarcinoma Through the Positive Feedback Loop Between PTGS2 Transcriptional Activation and Neutrophil Recruitment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 07, 2026

Targeted inactivation of protein disulfide-isomerase 1 by Lactobacillus reuteri-derived reuterin promotes intestinal stem cell proliferation via ROS signaling.

Targeted inactivation of protein disulfide-isomerase 1 by Lactobacillus reuteri-derived reuterin promotes intestinal stem cell proliferation via ROS signaling.

Journal: International journal of biological macromolecules

Published: January 04, 2026

O-GlcNAcylation of SPOP regulates colorectal cancer progression and ferroptosis by mediating β-catenin degradation.

O-GlcNAcylation of SPOP regulates colorectal cancer progression and ferroptosis by mediating β-catenin degradation.

Journal: Cell death discovery

Published: July 31, 2025

Recibokibart, an anti-IL-36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial.

Recibokibart, an anti-IL-36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 05, 2024

Characterization of ferroptosis-triggered pyroptotic signaling in heart failure.

Characterization of ferroptosis-triggered pyroptotic signaling in heart failure.

Journal: Signal transduction and targeted therapy

Published: March 12, 2024

ARIG inhibition improves the prognosis of liver cancer through autophagy regulation and tumor immunity enhancement.

ARIG inhibition improves the prognosis of liver cancer through autophagy regulation and tumor immunity enhancement.

Journal: Genes & diseases

Published: August 31, 2022

Novel insight into the role of immunotherapy in gastrointestinal cancer (Review).

Novel insight into the role of immunotherapy in gastrointestinal cancer (Review).

Journal: Molecular and clinical oncology

Published: July 12, 2022

Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma.

Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma.

Journal: Clinical and experimental medicine

Published: June 26, 2022

Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway.

Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway.

Journal: Frontiers in pharmacology

Published: January 03, 2022

Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy.

Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy.

Journal: BMC medicine

Published: December 20, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026